Cargando…

Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction

BACKGROUND: While aldosterone antagonists have proven benefit among post‐myocardial infarction (MI) patients with low ejection fraction (EF), how this treatment is used among older MI patients in routine practice is not well described. METHODS AND RESULTS: Using ACTION Registry‐GWTG linked to Medica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tracy Y., Vora, Amit N., Peng, S. Andrew, Fonarow, Gregg C., Das, Sandeep, de Lemos, James A., Peterson, Eric D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859378/ https://www.ncbi.nlm.nih.gov/pubmed/26796254 http://dx.doi.org/10.1161/JAHA.115.002612

Ejemplares similares

Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure
por: Greenberg, Barry, et al.
Publicado: (2019)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
por: McDiarmid, Adam K., et al.
Publicado: (2019)

Evaluation of aldosterone antagonist utilization in heart failure with reduced and preserved ejection fraction at an academic medical center
por: Bradley, Daniel, et al.
Publicado: (2019)

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan
por: Mayyas, Fadia, et al.
Publicado: (2017)

Global Benefit of SGLT2 Inhibitors in Heart Failure With Reduced Ejection Fraction
por: Brownell, Nicholas K., et al.
Publicado: (2022)

Prognosis after discontinuing renin angiotensin aldosterone system inhibitor for heart failure with restored ejection fraction after acute myocardial infarction
por: Lee, Seung Hun, et al.
Publicado: (2023)

Long‐Term Mortality of Older Patients With Acute Myocardial Infarction Treated in US Clinical Practice
por: Kochar, Ajar, et al.
Publicado: (2018)

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?
por: Rymer, Jennifer A., et al.
Publicado: (2019)

Assessment of Clopidogrel on the Left Ventricular Ejection Fraction in Acute Myocardial Infarction
por: Khosravi, Pejman, et al.
Publicado: (2010)

Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2019)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
por: Hegyi, Bence, et al.
Publicado: (2022)

The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
por: Brownell, Nicholas K, et al.
Publicado: (2021)

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) Study
por: Vora, Amit N., et al.
Publicado: (2016)

Corrected thrombolysis in myocardial infarction frame count and ejection fraction in patients undergoing primary percutaneous coronary intervention for myocardial infarction
por: Vakili, Hossein, et al.
Publicado: (2013)

Variability in Reassessment of Left Ventricular Ejection Fraction After Myocardial Infarction in the Acute Myocardial Infarction Quality Assurance Canada Study
por: Wilton, Stephen B., et al.
Publicado: (2021)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Association of Plasma Methylglyoxal Increase after Myocardial Infarction and the Left Ventricular Ejection Fraction
por: Heber, Stefan, et al.
Publicado: (2022)

Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex
por: Pickny, Lisa, et al.
Publicado: (2023)

Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic Therapy
por: Inohara, Taku, et al.
Publicado: (2019)

Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE‐ACS Study
por: Fanaroff, Alexander C., et al.
Publicado: (2017)

Recent US Patterns and Predictors of Prevalent Diabetes among Acute Myocardial Infarction Patients
por: Ovbiagele, Bruce, et al.
Publicado: (2011)

Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
por: Ye, Fanhao, et al.
Publicado: (2022)

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2017)

Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction
por: Nowosielski, Martha, et al.
Publicado: (2009)

Ejection Fraction and Mortality Rate of Patients with Isolated Acute Inferior Myocardial Infarction Reperfused by Streptokinase
por: Beiraghdar, Mozhdeh, et al.
Publicado: (2011)

Relationship between left ventricular ejection fraction and depression following myocardial infarction: an original article
por: Bagherian-Sararoudi, Reza, et al.
Publicado: (2013)

Eplerenone in patients with myocardial infarction and “mid‐range” ejection fraction: An analysis from the EPHESUS trial
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Predictive factors of left ventricular ejection fraction improvement after myocardial infarction treated invasively
por: Lazar, Monika, et al.
Publicado: (2023)

Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction
por: Sörensson, Peder, et al.
Publicado: (2013)

Management of Hypertensive Emergency in the Setting of Primary Aldosteronism Complicated by Heart Failure With Reduced Ejection Fraction
por: Sarguroh, Tauseef, et al.
Publicado: (2023)

Myocardial Contraction Fraction is Superior to Ejection Fraction in Predicting Functional Capacity in Patients with Heart Failure with Reduced Ejection Fraction
por: Abdellatif, Yasser A., et al.
Publicado: (2022)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Health-related quality of life after myocardial infarction is associated with level of left ventricular ejection fraction
por: Pettersen, Kjell I, et al.
Publicado: (2008)

Risk of ventricular arrhythmia in patients with myocardial infarction and non-obstructive coronary arteries and normal ejection fraction
por: Bière, Loïc, et al.
Publicado: (2017)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

Prognostic value of D‐dimer in acute myocardial infarction complicated by heart failure with preserved ejection fraction
por: Zhang, Xiaoyuan, et al.
Publicado: (2020)

Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries
por: Gao, Side, et al.
Publicado: (2021)

Correlation of left ventricular ejection fraction drop and fragmented QRS with ST-segment elevation myocardial infarction
por: Bordbar, Armin, et al.
Publicado: (2021)

Identifying a low‐flow phenotype in heart failure with preserved ejection fraction: a secondary analysis of the RELAX trial
por: Patel, Kershaw V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b0n1kem7am64ekk8c1ivnvshph